Prognostic Value of Baseline FDG Pet Parameters in High Risk Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology - United Kingdom
doi 10.1002/hon.80_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Diagnostic and Prognostic Value of Baseline FDG PET/CT Skeletal Textural Features in Diffuse Large B Cell Lymphoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2006English

Utility of Baseline Assessment With FDG-PET-CT Compared With CT Scanning in People With Diffuse Large B-Cell Lymphoma (DLBCL)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Reply: Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18f-FDG PET in Diffuse Large B-Cell Lymphoma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma

Sao Paulo Medical Journal
Medicine
2010English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

On the Added Value of Baseline FDG-PET in Malignant Lymphoma

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2009English

Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study

Blood Cancer Journal
OncologyHematology
2016English

Prognostic Significance of Serum Immunoglobulin Paraprotein in Patients With Diffuse Large B Cell Lymphoma

British Journal of Haematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy